Two airway clearance methods compared for people with COPD
Compares autogenic drainage with a flutter device for breathlessness in people with COPD.
Plain-language title generated from the registry record
Registry title: Effects of Autogenic Drainage and Flutter Device in COPD
Key facts
- Where
- Lahore, PakistanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 60 years old?
Source: NCT07713043, who can take part
Where in Pakistan
- Nimra NoorLahore, PakistanNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Riphah International University
- Trial code
- NCT07713043
- Record updated
- 20 July 2026
- Original description
COPD is a progressive lung disease that includes emphysema and chronic bronchitis and is a major cause of morbidity and mortality worldwide. Airway clearance techniques help improve mucus removal, reduce dyspnea, and enhance quality of life in COPD patients. This study aims to compare the effects of autogenic drainage and flutter device on dyspnea, pulmonary function, and functional capacity in patients with COPD. A randomized clinical trial will be conducted at Gulab Devi Teaching Hospital using convenient sampling. Participants will be divided into two groups: Group A will receive autogenic drainage, while Group B will use the flutter device. Interventions will be performed daily for 20-30 minutes over 6 weeks. Outcome measures will include dyspnea severity scale, spirometry, and 6-minute walk test. Data will be analyzed using SPSS with significance set at p < 0.05. The study may provide evidence for effective, non-invasive, and cost-effective management strategies for COPD patients.Read full original descriptionShow less
Comparative Effects of Autogenic Drainage and Flutter Device on Dyspnea, Pulmonary Function Test and Functional Capacity in COPD
COPD is a progressive lung disease that includes emphysema and chronic bronchitis and is a major cause of morbidity and mortality worldwide. Airway clearance techniques help improve mucus removal, reduce dyspnea, and enhance quality of life in COPD patients. This study aims to compare the effects of autogenic drainage and flutter device on dyspnea, pulmonary function, and functional capacity in patients with COPD. A randomized clinical trial will be conducted at Gulab Devi Teaching Hospital using convenient sampling. Participants will be divided into two groups: Group A will receive autogenic drainage, while Group B will use the flutter device. Interventions will be performed daily for 20-30 minutes over 6 weeks. Outcome measures will include dyspnea severity scale, spirometry, and 6-minute walk test. Data will be analyzed using SPSS with significance set at p < 0.05. The study may provide evidence for effective, non-invasive, and cost-effective management strategies for COPD patients.
Inclusion: Age group: Middle age adults (40-60 years), medically stable; Both gender; Diagnosis based on GOLD criteria ((FEV₁/FVC ratio < 0.70); Moderate COPD with no acute exacerbations in the past 4-6 weeks; Participants must be able to perform Autogenic drainage and Flutter device physically and mentally; Voluntary participation with consent.
Exclusion: Cardic Diseases (Acute MI, Congestive Heart Failure); Recent lung diseases (Respiratory failure, pneumothorax); Musculoskeletal Impairements; Using Non-invasive Ventilation; Hemodynamic instability; Uncoorperative patients; Cognitive Impairement scale; Participants excluded if they did not consent; Comorbidities affecting exercise tolerance.